Post Mastectomy Reconstruction denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for post mastectomy reconstruction are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Post-Mastectomy Reconstruction as Non-Formulary

A non-formulary denial in the context of post-mastectomy reconstruction is unusual and almost certainly an administrative classification error. Formulary denials are designed for pharmaceutical benefits — the plan's approved drug list — and should not apply to surgical procedures or reconstructive surgery. When this denial code appears for reconstruction, it typically means the procedure was routed through a benefits module or billing system that applied drug-coverage logic to a surgical claim.

Regardless of the administrative mechanism, this denial is legally vulnerable under the Women's Health and Cancer Rights Act (WHCRA) of 1998, which requires that plans covering mastectomy also cover all stages of reconstruction, symmetry procedures on the contralateral breast, prostheses, and treatment of physical complications. A non-formulary exclusion cannot be used to circumvent this federal obligation.

## Why It Is Appealable

Because the non-formulary classification is almost certainly a coding or routing error, this appeal is largely administrative in nature. The goal is to have the claim or authorization reclassified and reviewed under the correct surgical/medical benefits module, where WHCRA protections apply directly. This type of denial frequently resolves at the internal appeal stage once the error is identified.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): File a written internal appeal within the timeframe on the denial notice. Request that the reviewer confirm which benefits module governs the claim and whether WHCRA was applied.
• External review (ACA §2719): If the internal appeal is denied, you have approximately four months from the final denial to request independent external review.
• Expedited review: If your surgery has a time-sensitive clinical window, request expedited review simultaneously with your internal appeal.

## Concrete Appeal Steps and Timeline

1. Call BCBS member services and ask specifically: "Which benefits module was this claim reviewed under, and was WHCRA applied?" 2. Document the representative's name, date, and response. 3. Submit a written internal appeal citing the apparent misclassification and invoking WHCRA. 4. Attach documentation of the mastectomy and the reconstruction plan to anchor the clinical context. 5. If not resolved internally, proceed to external review.

## Documentation to Gather

• Diagnosis and surgical history: Pathology report, mastectomy operative note, and oncology records.
• Reconstruction plan: Your surgeon's operative plan confirming this is a post-mastectomy reconstruction procedure.
• Denial letter and EOB: Keep the original denial documents to demonstrate the non-formulary code was applied to a surgical procedure.
• WHCRA citation: Cite the statute in your appeal letter and note that it prohibits plans from applying formulary-type exclusions to required reconstruction coverage.
• Member services call log: Written record of any phone clarification you obtained.

## Criteria-Mapping Structure

Because the core issue is misclassification rather than clinical criteria, your mapping should be brief and focused: (1) confirm the procedure is post-mastectomy reconstruction, (2) confirm WHCRA applies to your plan, and (3) state that no formulary criterion is relevant to a surgical procedure covered by federal statute. If BCBS offers a corrected review under the right benefits module, then map the clinical facts to its published medical/coverage policy criteria as described in the medical-necessity appeal guidance.